# Cancer Drugs Get 30% Trade Margin Cap

> Experts finalize cancer drugs list under 30% trade margin cap to save ₹2,500 crore annually.
- Title: Cancer Drugs Get 30% Trade Margin Cap · The Economic Times
- Summary: Experts finalize cancer drugs list under 30% trade margin cap to save ₹2,500 crore annually. India's government caps trade margins on cancer drugs at 30%…
- Keywords: cancer drugs, trade margin cap, nppa, tata memorial centre, drug pricing, annual savings, Cancer, Drugs, Get, Trade, Margin, Cap
- Source: The Economic Times — https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/panel-to-finalise-cancer-drugs-for-30-trade-margin-cap-rs-2500-crore-annual-savings-possible/articleshow/134901994.cms
- Author: Teena Thacker
- Published: 2026-10-12T20:10:00+00:00
- Read time: 1 min
- Topics: cancer drugs, trade margin cap, nppa, tata memorial centre, drug pricing, annual savings
## Experts to finalize cancer drugs list
A group of experts including doctors from Tata Memorial Centre and NPPA officials will finalize cancer medicines covered under a 30% trade margin cap by Wednesday.
## 30% trade margin cap reduces prices
The government caps trade margins on non-scheduled anti-cancer medicines at 30%, potentially lowering maximum retail prices by up to 70%.
## Annual savings of ₹2,500 crore
This move could save patients an estimated ₹2,500 crore annually through reduced prices on cancer drugs.
## Market analysis shows high markups
NPPA analysis found non-scheduled anti-cancer medicines had average trade markups of 170% with some reaching up to 700%.
## Trade margin rationalisation applies broadly
The trade margin rationalisation exercise covers branded and generic drugs, domestic and imported products, and both patented and non-patented medicines.
## Savings expected to last
The positive list may be updated periodically based on market developments and public health considerations to maintain savings.
## Key takeaway

India's government caps trade margins on cancer drugs at 30%, potentially saving patients ₹2,500 crore yearly.